High-performance liquid chromatography separation of aminopterin-polyglutamates within red blood cells of children treated for acute lymphoblastic leukemia

Translational Research

Volumn 150, Issue 6, 2007, Pages 367-373

  Vijayanathan, Veena ^a   Smith, Angela K ^a   Zebala, John A ^b   Kamen, Barton A ^a,c   Cole, Peter D ^a,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b SYNTRIX BIOSYSTEMS INC   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPTERIN; METHOTREXATE; POLYGLUTAMIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; ERYTHROCYTE; FEMALE; HEMATOLOGIC DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPHIL COUNT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEPARATION TECHNIQUE;

EID: 36049032494     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.08.002     Document Type: Article

References (35)

1. Schroder H. Methotrexate pharmacokinetics in age-fractionated erythrocytes. Cancer Chemother Pharmacol 18 (1986) 203-207
2. Schroder H. In vivo methotrexate kinetics and metabolism in human hematopoietic cells. Clinical significance of methotrexate concentrations in erythrocytes. Dan Med Bull 37 (1990) 22-40
3. da Costa M., and Iqbal M.P. The transport and accumulation of methotrexate in human erythrocytes. Cancer 48 (1981) 2427-2432
4. Krakower G.R., and Kamen B.A. The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ. J Pharmacol Exp Ther 231 (1984) 43-47
5. Hendel J., and Nyfors A. Pharmacokinetics of methotrexate in erythrocytes in psoriasis. Eur J Clin Pharmacol 27 (1984) 607-610
6. Schroder H., Clausen N., Ostergaard E., and Pressler T. Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment. Cancer Chemother Pharmacol 16 (1986) 190-193
7. Schmiegelow K., Schroder H., Gustafsson G., et al. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology. J Clin Oncol 13 (1995) 345-351
8. Schmiegelow K., Schroder H., Pulczynska M.K., and Hejl M. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes. Cancer Chemother Pharmacol 25 (1989) 65-69
9. Schmiegelow K., Schroder H., and Schmiegelow M. Methotrexate and 6-mercaptopurine maintenance therapy for childhood acute lymphoblastic leukemia: dose adjustments by white cell counts or by pharmacokinetic parameters?. Cancer Chemother Pharmacol 34 (1994) 209-215
10. Schmiegelow K., Bjork O., Glomstein A., et al. Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia. J Clin Oncol 21 (2003) 1332-1339
11. Graham M.L., Shuster J.J., Kamen B.A., et al. Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study. Cancer Chemother Pharmacol 31 (1992) 217-222
12. Dervieux T., Furst D., Lein D.O., et al. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum 50 (2004) 2766-2774
13. Dervieux T., Furst D., Orentas Lein D., et al. Pharmacogenetic and metabolite measurements are associated with clinical status in rheumatoid arthritis patients treated with methotrexate: results of a multicentred cross sectional observational study. Ann Rheum Dis 64 (2005) 1180-1185
14. Burchenal J.H., Burchenal J.R., Kushida M.W., Johnston S.F., and Williams B.S. Studies on the chemotherapy of leukemia. Cancer 2 (1949) 113-118
15. Schoenbach E.B., Colsky J., and Greenspan E.M. Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms. Cancer 5 (1952) 1201-1220
16. Farber S., Toch R., Sears E.M., and Pinkel D. Advances in chemotherapy of cancer in man. In: Greenstein H.A. (Ed). Advances in cancer research (1956), Academic Press, New York 2-73
17. Dacie J.V., Dresner E., Mollin D.L., and White J.C. Aminopterin in the treatment of acute leukemia. Br Med J 1 (1950) 1447-1457
18. Goldin A., Venditti J.M., Humphreys S.R., Dennis D., and Mantel N. A quantitative comparison of the antileukemic effectiveness of two folic acid antagonists in mice. J Natl Can Inst 15 (1955) 1657-1664
19. Smith A., Hum M., Winick N.J., and Kamen B.A. A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro. Clin Cancer Res 2 (1996) 69-73
20. Cole P.D., Drachtman R.A., Smith A.K., et al. Phase II trial of oral aminopterin for adults and children with refractory acute leukemia. Clin Cancer Res 11 (2005) 8089-8096
21. Ratliff A.F., Wilson J., Hum M., et al. Phase I and pharmacokinetic trial of aminopterin in patients with refractory malignancies. J Clin Oncol 16 (1998) 1458-1464
22. Balis F.M., Savitch J.L., and Bleyer W.A. Pharmacokinetics of oral methotrexate in children. Cancer Res 43 (1983) 2342-2345
23. Kearney P.J., Light P.A., Preece A., and Mott M.G. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia. Cancer Chemother Pharmacol 3 (1979) 117-120
24. Cole P.D., Zebala J.A., Alcaraz M.J., Smith A.K., Tan J., and Kamen B.A. Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy. Cancer Chemother Pharmacol 57 (2006) 826-834
25. Winick N., Shuster J.J., Bowman W.P., et al. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. J Clin Oncol 14 (1996) 2803-2811
26. Piper J.R., and Montgomery J.A. A convenient synthesis of aminopterin and homologues via 6-(bromethyl)-2, 4-disminopteridine hydrobromide. J Heterocyclic Chem 11 (1974) 279-280
27. Cole P.D., Drachtman R.A., Smith A.K., et al. Phase II trial of oral aminopterin for adults and children with refractory acute leukemia. Clin Cancer Res 11 (2005) 8089-8096
28. Zebala J.A. Facile process for the preparation of high-purity aminopterin (2007) United States Patent 7235660. June 26
29. Kamen B.A., Takach P.L., Vatev R., and Caston J.D. A rapid, radiochemical-ligand binding assay for methotrexate. Anal Biochem 70 (1976) 54-63
30. Schroder H., Fogh K., and Herlin T. In vivo decline of methotrexate and methotrexate polyglutamates in age-fractionated erythrocytes. Cancer Chemother Pharmacol 21 (1988) 150-155
31. Schroder H., and Fogh K. Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 21 (1988) 145-149
32. Kremer J.M., Galivan J., Streckfuss A., and Kamen B. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 29 (1986) 832-835
33. Dervieux T., Orentas Lein D., Marcelletti J., et al. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis. Clin Chem 49 (2003) 1632-1641
34. Kuehl M., Brixner D.I., Broom A.D., Avery T.L., and Blakley R.L. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice. Cancer Res 48 (1988) 1481-1488
35. Samuels L.L., Moccio D.M., and Sirotnak F.M. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro. Cancer Res 45 (1985) 1488-1495